Global Hydroxyapatite Market 2021
Hydroxyapatite, also called hydroxylapatite (HA), is a naturally occurring mineral form of calcium apatite with the formula Ca5(PO4)3(OH). Hydroxyapatite is a major component and an essential ingredient of normal bone and teeth. It makes up bone mineral and the matrix of teeth. The global hydroxyapatite market in terms of revenue is set to grow by US$ 881 million during 2021-2027, growing at a compound annual growth rate (CAGR) of 5.4% during the forecast period, according to data and analytics company StrategyHelix. Increasing demand for bone transplants and bone grafting material, rising disposable income in emerging countries are the key factors driving market growth.
The report provides up-to-date market size data for period 2017-2020 and forecast to 2027 covering key market aspects like sales value for hydroxyapatite. The global hydroxyapatite market is segmented on the basis of source, product, application, and region. By source, it is categorized into synthetic, and natural. The synthetic segment held the largest market share in 2020. By product, the hydroxyapatite market is divided into nano size, micro size, and greater than micrometer. The micro size segment accounted for the largest market share in 2020. Based on application, the hydroxyapatite market is divided into orthopedic, dental care, plastic surgery, and others.
The report has profiled some of the key players of the market such as APS Materials Inc., Berkeley Advanced Biomaterials Inc., Bionnovation Biomedical, CAM Bioceramics BV, CG Bio Inc., Evonik Industries AG, FLUIDINOVA S.A., GranuLab (M) Sdn Bhd, Merz Biomaterials (Merz North America Inc.), SigmaGraft Inc, SofSera Corporation, Taihei Chemical Industrial Co. Ltd..
The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the hydroxyapatite market to help drive informed decision making for industry executives, policy makers, academic, and analysts.
Report Scope
Source: synthetic, and natural
Product: nano size, micro size, and greater than micrometer
Application: orthopedic, dental care, plastic surgery, and others
Region: North America, Asia Pacific, Europe, and Rest of the World (ROW)
Years Considered: this report covers the period 2017 to 2027
Key Benefits for Stakeholders
Get a comprehensive picture of the global hydroxyapatite market
Identify regional strategies and strategic priorities on the basis of local data and analysis
Pinpoint growth sectors and trends for investment
Understand what the future of the global hydroxyapatite market looks like
Identify the competitive landscape and window of opportunity
The report provides up-to-date market size data for period 2017-2020 and forecast to 2027 covering key market aspects like sales value for hydroxyapatite. The global hydroxyapatite market is segmented on the basis of source, product, application, and region. By source, it is categorized into synthetic, and natural. The synthetic segment held the largest market share in 2020. By product, the hydroxyapatite market is divided into nano size, micro size, and greater than micrometer. The micro size segment accounted for the largest market share in 2020. Based on application, the hydroxyapatite market is divided into orthopedic, dental care, plastic surgery, and others.
The report has profiled some of the key players of the market such as APS Materials Inc., Berkeley Advanced Biomaterials Inc., Bionnovation Biomedical, CAM Bioceramics BV, CG Bio Inc., Evonik Industries AG, FLUIDINOVA S.A., GranuLab (M) Sdn Bhd, Merz Biomaterials (Merz North America Inc.), SigmaGraft Inc, SofSera Corporation, Taihei Chemical Industrial Co. Ltd..
The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the hydroxyapatite market to help drive informed decision making for industry executives, policy makers, academic, and analysts.
Report Scope
Source: synthetic, and natural
Product: nano size, micro size, and greater than micrometer
Application: orthopedic, dental care, plastic surgery, and others
Region: North America, Asia Pacific, Europe, and Rest of the World (ROW)
Years Considered: this report covers the period 2017 to 2027
Key Benefits for Stakeholders
Get a comprehensive picture of the global hydroxyapatite market
Identify regional strategies and strategic priorities on the basis of local data and analysis
Pinpoint growth sectors and trends for investment
Understand what the future of the global hydroxyapatite market looks like
Identify the competitive landscape and window of opportunity
1. MARKET DEFINITION
2. RESEARCH METHODOLOGY
3. MARKET DATA & OUTLOOK
3.1 Market Value
3.2 Market Value Forecast
4. HYDROXYAPATITE MARKET BY SOURCE
4.1 Synthetic
4.2 Natural
5. HYDROXYAPATITE MARKET BY PRODUCT
5.1 Nano Size
5.2 Micro Size
5.3 Greater Than Micrometer
6. HYDROXYAPATITE MARKET BY APPLICATION
6.1 Orthopedic
6.2 Dental Care
6.3 Plastic Surgery
6.4 Others
7. HYDROXYAPATITE MARKET BY REGION
7.1 North America
7.2 Asia Pacific
7.3 Europe
7.4 Rest Of The World (Row)
8. COMPANY PROFILES
8.1 APS Materials, Inc.
8.2 Berkeley Advanced Biomaterials, Inc.
8.3 Bionnovation Biomedical
8.4 CAM Bioceramics BV
8.5 CG Bio Inc.
8.6 Evonik Industries AG
8.7 FLUIDINOVA S.A.
8.8 GranuLab (M) Sdn Bhd
8.9 Merz Biomaterials (Merz North America, Inc.)
8.10 SigmaGraft, Inc
8.11 SofSera Corporation
8.12 Taihei Chemical Industrial Co., Ltd.
9. APPENDIX
9.1 About StrategyHelix
9.2 Disclaimer
2. RESEARCH METHODOLOGY
3. MARKET DATA & OUTLOOK
3.1 Market Value
3.2 Market Value Forecast
4. HYDROXYAPATITE MARKET BY SOURCE
4.1 Synthetic
4.2 Natural
5. HYDROXYAPATITE MARKET BY PRODUCT
5.1 Nano Size
5.2 Micro Size
5.3 Greater Than Micrometer
6. HYDROXYAPATITE MARKET BY APPLICATION
6.1 Orthopedic
6.2 Dental Care
6.3 Plastic Surgery
6.4 Others
7. HYDROXYAPATITE MARKET BY REGION
7.1 North America
7.2 Asia Pacific
7.3 Europe
7.4 Rest Of The World (Row)
8. COMPANY PROFILES
8.1 APS Materials, Inc.
8.2 Berkeley Advanced Biomaterials, Inc.
8.3 Bionnovation Biomedical
8.4 CAM Bioceramics BV
8.5 CG Bio Inc.
8.6 Evonik Industries AG
8.7 FLUIDINOVA S.A.
8.8 GranuLab (M) Sdn Bhd
8.9 Merz Biomaterials (Merz North America, Inc.)
8.10 SigmaGraft, Inc
8.11 SofSera Corporation
8.12 Taihei Chemical Industrial Co., Ltd.
9. APPENDIX
9.1 About StrategyHelix
9.2 Disclaimer
